Compounds > ciprofloxacin

ciprofloxacin and 1-(1-naphthylmethyl)piperazine

ciprofloxacin has been researched along with 1-(1-naphthylmethyl)piperazine in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's5 (83.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bohnert, JA; Karamian, B; Nikaido, H1
Bayram, Z; Coban, AY; Durupinar, B; Sezgin, FM1
Coban, AY; Durupinar, B; Guney, AK; Tanriverdi Cayci, Y1
Du, R; Guo, N; Jin, J; Jin, Q; Li, L; Li, Z; Liang, J; Liu, M; Wang, X; Wu, X; Yu, L1
Klančnik, A; Kurinčič, M; Smole Možina, S1
Mavri, A; Smole Možina, S1

Other Studies

6 other study(ies) available for ciprofloxacin and 1-(1-naphthylmethyl)piperazine

ArticleYear
Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:9

    Topics: Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chlortetracycline; Dipeptides; Doxorubicin; Doxycycline; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Minocycline; Onium Compounds; Organophosphorus Compounds; Tetracycline

2010
[Effect of efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine to MIC values of ciprofloxacin in ciprofloxacin resistant gram-negative bacteria].
    Mikrobiyoloji bulteni, 2009, Volume: 43, Issue:3

    Topics: Anti-Infective Agents; Ciprofloxacin; Drug Interactions; Drug Resistance, Bacterial; Escherichia coli; Humans; Klebsiella pneumoniae; Membrane Transport Proteins; Microbial Sensitivity Tests; Piperazines; Pseudomonas aeruginosa

2009
Effect of 1-(1-Naphtylmethyl)-piperazine, an efflux pump inhibitor, on antimicrobial drug susceptibilities of clinical Acinetobacter baumannii isolates.
    Current microbiology, 2011, Volume: 62, Issue:2

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Enzyme Inhibitors; Gentamicins; Humans; Meropenem; Microbial Sensitivity Tests; Piperazines; Thienamycins

2011
Synergistic activity of 1-(1-naphthylmethyl)-piperazine with ciprofloxacin against clinically resistant Staphylococcus aureus, as determined by different methods.
    Letters in applied microbiology, 2011, Volume: 52, Issue:4

    Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Drug Synergism; Fluoroquinolones; Methicillin-Resistant Staphylococcus aureus; Piperazines

2011
Effects of efflux pump inhibitors on erythromycin, ciprofloxacin, and tetracycline resistance in Campylobacter spp. isolates.
    Microbial drug resistance (Larchmont, N.Y.), 2012, Volume: 18, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Campylobacter coli; Campylobacter jejuni; Catechin; Ciprofloxacin; Dipeptides; Drug Resistance, Multiple, Bacterial; Erythromycin; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Piperazines; Tetracycline Resistance

2012
Resistance to bile salts and sodium deoxycholate in macrolide- and fluoroquinolone-susceptible and resistant Campylobacter jejuni and Campylobacter coli strains.
    Microbial drug resistance (Larchmont, N.Y.), 2013, Volume: 19, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Bile Acids and Salts; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; Deoxycholic Acid; Dipeptides; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Humans; Macrolides; Microbial Sensitivity Tests; Mutation; Piperazines; Poultry; Swine

2013